Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV003989869 | SCV004807990 | uncertain significance | Pseudohypoparathyroidism type 1B | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004532248 | SCV004748638 | uncertain significance | GNAS-related disorder | 2024-01-23 | no assertion criteria provided | clinical testing | The GNAS c.264_*2delATA variant is predicted to result in extension of the open reading frame (p.*88Tyrext*2). This variant corresponds to an intronic position in the primary GNAS transcript (NM_000516.7:c.257+970_257+972del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0053% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |